Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al

J Clin Oncol. 2014 Apr 20;32(12):1283-4. doi: 10.1200/JCO.2013.54.4437. Epub 2014 Mar 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Neoadjuvant Therapy*